Daily Bulletin


The Conversation

  • Written by Craig Gedye, Oncologist and Senior Lecturer, University of Newcastle

This year’s award of the Nobel Prize for Physiology and Medicine to Dr James P. Allison and Tasuku Honjo, for their work in the early 1990s on immune checkpoint proteins CTLA4 and PD1, is a fitting recognition of how their work has led to a seismic shift in the way we treat cancer.

Read more: James Allison and Tasuku Honjo: deserving winners of this year's Nobel Prize in Physiology or Medicine

In a remarkably short time, drugs that inhibit these immune checkpoints (or immune brakes) have transformed the practice of clinical oncology. Drugs like pembrolizumab (Keytruda), ipilimumab (Yervoy), nivolumab (Opdivo), avelumab, durvalumab (Imfinzi) and atezolizumab – some of which are now being subsidised on Australia’s Pharmaceutical Benefits Scheme (PBS) – are being applied across a range of cancers.

From AFL player Jarryd Roughead to businessman Ron Walker, to former US president Jimmy Carter, anecdotes abound for the activity of immune checkpoint inhibitors in advanced cancers such as melanoma, lung, kidney and bladder and others.

How two 1990s discoveries have led to (some) cured cancers, and a Nobel Prize James P. Allison studied the T-cell protein CTLA-4 and how it could help with cancer treatment. JUSTIN LANE/EPA/AAP

One of the first patients I was privileged to care for in clinic had completed four rounds of treatment with an experimental drug – three months of infusions of a checkpoint inhibitor (one of which is now on the PBS). She had managed these infusions well, but past treatments had failed, so she was understandably anxious.

Before going to see her, I checked her scan report.

Then I looked at the scans.

I checked the report again.

My first words when I walked into her room were ones I never dreamed I’d say to someone with advanced cancer: “I can’t see the cancer on your scans anymore”. My entrance would have been a lot more dramatic if the nurse hadn’t already told her the good news.

“When can I book a holiday?” she said.

Originally, Allison and Honjo’s studies were focused on the underlying machinery of how the immune system controls itself. Like many mechanisms in our body, the immune system has the ability to sense prevailing conditions and rapidly amplify a response to defend the body.

Read more: Explainer: how does the immune system work?

This powerful process has evolved over millions of years. But a powerful system also needs powerful regulation, for which our bodies have evolved so-called “checkpoints”, or brakes, that guard against overactivity of the immune response.

How two 1990s discoveries have led to (some) cured cancers, and a Nobel Prize Tasuku Honjo discovered PD-1, a protein expressed on the surface of certain immune cells. Jiji Press/EPA/AAP

There are myriad immune checkpoint proteins on the surface of immune cells and normal cells of the body to allow this regulation to occur. Immune checkpoints work in a committee to vote their approval or disapproval of whether an immune cell becomes activated and attacks when it meets and recognises another cell or organism.

Insufficient or impaired checkpoint signalling allows an overreaction, which may contribute to the causes of autoimmune diseases such as colitis and arthritis. Conversely overactivity of immune checkpoints can obscure and confuse the immune system, allowing infected or abnormal cells to persist.

Cancer cells use these immune checkpoints to hide and evade from immune cells, tipping the balance in favour of the cancer and turning each immune cell off. Checkpoint inhibitor drugs work by not allowing the brakes to come on, so the immune system can keep attacking the cancer.

Read more: The fourth pillar: how we're arming the immune system to help fight cancer

Allison and Tashuka initially conceived that their discoveries may help treat chronic infections such as hepatitis B and C. The drugs created from their discoveries remain in trials for these conditions, but their most exciting application has come through the treatment of cancer.

Using the power of the immune system to fight off cancer actually goes back to the late 19th century. Surgeon William Coley had developed an approach to treating cancer that involved injecting patients with a mixture of heat-killed bacteria in the hopes of stimulating the body’s “resisting powers.”

But with rapid understanding of the physics of radiotherapy, and the chemistry of chemotherapy, the use of immune therapy for cancer languished. It waited until we had a better understanding of the biology of the immune system.

We now know that the current crop of immune checkpoint inhibitor drugs will help a minority of patients across many cancers, but still fail the majority. Our understanding still feels very basic. We can’t yet predict who will be helped, who will be failed, who will suffer side-effects, or who will benefit from different combinations of therapy.

But this platform of studies and drugs will provide us with the foundation to understand how the immune system is structured and could be reactivated in every person with cancer, to try to solve this puzzle in real-time for each individual.

The work of Allison and Honjo has given us hope of delivering mundane miracles to everyone with cancer, and turning cancer patients back into people.

Read more: Cancer immunotherapy drugs like Keytruda and Opdivo hold hope for some, but there's still a way to go

Authors: Craig Gedye, Oncologist and Senior Lecturer, University of Newcastle

Read more http://theconversation.com/how-two-1990s-discoveries-have-led-to-some-cured-cancers-and-a-nobel-prize-104221

Writers Wanted

New modelling finds investing in childcare and aged care almost pays for itself

arrow_forward

Review: Robert Dessaix on growing older well — a genial journey through a rich inner world

arrow_forward

The Conversation
INTERWEBS DIGITAL AGENCY

Politics

Prime Minister Interview with Kieran Gilbert, Sky News

KIERAN GILBERT: Kieran Gilbert here with you and the Prime Minister joins me. Prime Minister, thanks so much for your time.  PRIME MINISTER: G'day Kieran.  GILBERT: An assumption a vaccine is ...

Daily Bulletin - avatar Daily Bulletin

Did BLM Really Change the US Police Work?

The Black Lives Matter (BLM) movement has proven that the power of the state rests in the hands of the people it governs. Following the death of 46-year-old black American George Floyd in a case of ...

a Guest Writer - avatar a Guest Writer

Scott Morrison: the right man at the right time

Australia is not at war with another nation or ideology in August 2020 but the nation is in conflict. There are serious threats from China and there are many challenges flowing from the pandemic tha...

Greg Rogers - avatar Greg Rogers

Business News

Top 3 Accident Law Firms of Riverside County, CA

Do you live in Riverside County and faced an accident and now looking for a trusted Law firm to present your case? If yes, then you have come to the right place. The purpose of the article is to...

News Co - avatar News Co

3 Ways to Keep Your Business Safe with Roller Shutters

If you operate your business in a neighbourhood or city that is not known for being a safe environment, it is not surprising if you often worry about the safety of your business establishments o...

News Co - avatar News Co

Expert Tips on How to Create a Digital Product to Sell on Your Blog

As the managing director of a growing talent agency, I use the company blog to not only promote my business but as a way to establish ourselves as an authority in our industry. You see, blogs a...

Adam Jacobs - avatar Adam Jacobs



News Co Media Group

Content & Technology Connecting Global Audiences

More Information - Less Opinion